NeurogesX, Inc.(fka NGSX)

[bob smith]

will be dependant on cost control of the product with availability concerns.

first thing first would, would be approval.

over time distribution and cost control would take care of itself and will be addressed at next conference call, expected twds the end of the month of march


gl